Rothschild Investment »

Perspective Therapeutics shares owned by Rothschild Investment

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Rothschild Investment from 13F filings

Historical chart of Rothschild Investment investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Rothschild Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Rothschild Investment

Quarter filed Position value Share count Share price at filing
2025-12-31 $19 7 2.71
2024-09-30 $734 55 13.35

More positions owned by Rothschild Investment

Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Microsoft Corp Stock (MSFT)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Blackstone Stock (BX)
Invesco Rafi Us 1000 Etf Etf (PRF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Amazon Stock (AMZN)
Abbvie Stock (ABBV)
Capital Group Dividend Growers Etf Etf (CGDG)
Johnson & Johnson Stock (JNJ)
Meta Platforms Inc Cl A Stock (META)
Chevron Corporation Stock (CVX)

View all positions for Rothschild Investment

Top funds holding Perspective Therapeutics

FMR
BlackRock
Vanguard Group
Avidity Partners Management
Millennium Management
Nicholson Wealth Management Group
Geode Capital Management
Nuveen
Opaleye Management
State Street Corporation
Patient Square Capital
Hills Bank And Trust Company
UBS Group
Charles Schwab Investment Management
Two Sigma Investments

View all funds holding Perspective Therapeutics